Announcements Trials
Browse Landscape

Phase

Phase 2 63Phase NA 37Phase 1/2 20Phase 1 18Phase 3 5Phase 4 2Phase EARLY_PHASE1 1

Status

Completed 56Active not recruiting 20Recruiting 16Terminated 12Unknown 5Not yet recruiting 4Withdrawn 3

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 1

Conditions

Breast Neoplasms 143Colorectal Neoplasms 97Carcinoma, Non-Small-Cell Lung 97Carcinoma, Hepatocellular 69Stomach Neoplasms 65Rectal Neoplasms 54Neoplasms 53Lung Neoplasms 45Colonic Neoplasms 41Nasopharyngeal Carcinoma 39Leukemia, Myeloid, Acute 39Prostatic Neoplasms 38Lymphoma, Large B-Cell, Diffuse 38Uterine Cervical Neoplasms 36Neoplasm Metastasis 33Ovarian Neoplasms 32Esophageal Neoplasms 32Multiple Myeloma 31Lymphoma 31Lymphoma, Follicular 30Leukemia 28Pancreatic Neoplasms 27Recurrence 22Head and Neck Neoplasms 22Brain Neoplasms 21Urinary Bladder Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, Non-Hodgkin 19Squamous Cell Carcinoma of Head and Neck 17Lymphoma, Mantle-Cell 17

Interventions

Minocycline 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Carcinoma, Renal Cell × Clear all
NCT04764487 2022-05-03

AxiPRO

Weprom

Phase 3 Unknown
178 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02928692 2020-01-28

MAPOCD

RenJi Hospital

Phase 3 Unknown
750 enrolled
GastrointestinalGenitourinary

cyclopia sequence, Emergence Delirium, Postoperative Cognitive Complications, Carcinoma, Renal Cell, Colonic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms

NCT01099423 2017-02-08

SURTIME

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Unknown
99 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01481870 2013-02-25

CROSS-J-RCC

Yamagata University

Phase 3 Unknown
120 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00869011 2009-12-23

Exercise for Patients With Renal Cell Cancer Receiving Sunitinib

Charite University, Berlin, Germany

Phase 3 Unknown
70 enrolled
Genitourinary

Carcinoma, Renal Cell, Fatigue, Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡